CYCLO THERAPEUTICS $CYTH CATALYST
$CYTH Cyclo Threrapeutics has a major catalyst tomorrow. Closed at $11.22 today and peaked at around $15 a few weeks back, its ready to blow up after tomorrow. Heres why,
Cyclo Therapeutics, a clinical stage biotechnology company developing a cyclodextrin platform for the treatment of Neurodegenerative Diseases, including their lead candidate (Trappsol® Cyclo™) in the treatment of Niemann-Pick Disease Type C (NPC),announced details for the Company’s upcoming presentations at the 17th Annual WORLDSymposium 2021, a leading medical and scientific conference for professionals working to advance understanding and treatments for lysosomal storage diseases, including NPC. The conference will be held virtually at 230pmET tomorrow. Target at $20.